Abbott Laboratories (ABT)

Growth

Revenue 5Y11.43%
Revenue 3Y11.77%
EPS 5Y33.24%
EPS 3Y43.58%
Dividend 5Y11.59%
Dividend 3Y17.15%

Capital Efficiency

ROIC15.88%
ROE22.01%
ROA10.84%
ROTA12.73%

Capital Structure

Market Cap195.72B
EV202.54B
Cash9.59B
Current Ratio1.86
Debt/Equity0.51
Net Debt/EBITDA0.52
Show More

Ratios

Select a metric from the list below to chart it

Dec '85
Dec '92
Dec '99
Dec '06
Dec '13
Dec '20
Ratios
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Price to Book Ratio
2.2
3.1
2.6
2.9
3.5
4.1
5.1
6.7
6.2
3.9
Price to Book Ratio % Chg.
14.6%
39.6%
-16.2%
11.9%
19.8%
17.0%
22.6%
32.1%
-7.1%
-37.0%
Price to Earnings Ratio
22.0
29.6
12.6
43.1
228.2
53.1
42.6
48.7
31.4
17.7
Price to Earnings Ratio % Chg.
149.9%
34.6%
-57.4%
242.4%
429.0%
-76.7%
-19.8%
14.3%
-35.5%
-43.8%
Price to Free Cash Flow Ratio
26.0
26.0
30.0
29.0
24.5
25.7
34.9
38.2
25.7
16.3
Price to Free Cash Flow Ratio % Chg.
272.6%
0.1%
15.6%
-3.4%
-15.4%
4.5%
36.2%
9.5%
-32.9%
-36.5%
Price to Operating Cash Flow Ratio
17.0
18.4
18.8
18.9
19.5
20.0
25.6
27.7
21.1
13.5
Price to Operating Cash Flow Ratio % Chg.
202.6%
8.0%
2.3%
0.3%
3.6%
2.2%
28.2%
8.2%
-23.9%
-36.0%
Price Earnings to Growth Ratio
-0.4
-3.3
0.1
-0.6
-3.2
0.1
0.8
2.3
0.5
0.5
Price Earnings to Growth Ratio % Chg.
-
739.5%
-
-
407.7%
-
472.2%
195.3%
-76.0%
-9.1%
Price to Sales Ratio
2.6
3.3
2.7
2.9
4.0
4.1
4.9
6.3
5.2
3.1
Price to Sales Ratio % Chg.
97.1%
28.8%
-18.1%
6.0%
37.2%
3.5%
19.7%
28.4%
-18.5%
-40.0%
EV to EBITDA
13.0
14.9
9.0
18.0
20.3
20.2
22.1
26.1
18.8
11.1
EV to EBITDA % Chg.
101.8%
14.8%
-39.6%
100.5%
12.4%
-0.5%
9.4%
18.3%
-28.0%
-41.2%